Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study

被引:70
作者
Cantini, Fabrizio [1 ]
Niccoli, Laura [1 ]
Nannini, Carlotta [1 ]
Matarrese, Daniela [2 ]
Di Natale, Massimo Edoardo [3 ]
Lotti, Pamela [3 ]
Aquilini, Donatella [4 ]
Landini, Giancarlo [5 ]
Cimolato, Barbara [5 ]
Di Pietro, Massimo Antonio [6 ]
Trezzi, Michele [6 ]
Stobbione, Paolo [7 ]
Frausini, Gabriele [8 ]
Navarra, Assunta [9 ]
Nicastri, Emanuele [10 ]
Sotgiu, Giovanni [11 ]
Goletti, Delia [12 ]
机构
[1] Hosp Prato, Azienda USL Toscana Ctr, Dept Rheumatol, Prato, Italy
[2] Hosp Prato, Azienda USL Toscana Ctr, Sanit Direct, Prato, Italy
[3] Hosp Prato, Azienda USL Toscana Ctr, Div Internal Med 2, Prato, Italy
[4] Hosp Prato, Azienda USL Toscana Ctr, Div Infect Dis, Prato, Italy
[5] Santa Maria Nuova Hosp, Azienda USL Toscana Ctr, Dept Med Specialties, Div Internal Med, Florence, Italy
[6] Hosp Pistoia, Azienda USL Toscana Ctr, Div Infect Dis, Pistoia, Italy
[7] AO SS Antonio & Biagio & C Arrigo, Rheumatol Unit, Alessandria, Italy
[8] Osped Riuniti Marche Nord, Azienda Osped, Div Internal Med, Fano Pesaro, Italy
[9] Natl Inst Infect Dis, Clin Epidemiol Unit, Rome, Italy
[10] IRCCS, Clin Div Infect Dis, Natl Inst Infect Dis, Rome, Italy
[11] Univ Sassari, Clin Epidemiol & Med Stat Unit, Dept Med Surg & Expt Sci, Sassari, Italy
[12] IRCCS, Translat Res Unit, Dept Epidemiol & Preclin Res, L Spallanzani Natl Inst Infect Dis INMI, Rome, Italy
关键词
D O I
10.1016/j.jinf.2020.06.052
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:673 / 677
页数:5
相关论文
共 9 条
[1]   Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan [J].
Adachi, Takuya ;
Chong, Ja-Mun ;
Nakajima, Noriko ;
Sano, Masahiro ;
Yamazaki, Jun ;
Miyamoto, Ippei ;
Nishioka, Haruka ;
Akita, Hidetaka ;
Sato, Yuko ;
Kataoka, Michiyo ;
Katano, Harutaka ;
Tobiume, Minoru ;
Sekizuka, Tsuyoshi ;
Itokawa, Kentaro ;
Kuroda, Makoto ;
Suzuki, Tadaki .
EMERGING INFECTIOUS DISEASES, 2020, 26 (09) :2157-2161
[2]  
[Anonymous], 2020, EMBO MOL MED, DOI DOI 10.15252/emmm.202012697
[3]  
Cantini F, 2020, J INFECTION, V81, P318, DOI [10.1016/j.jinf.2020.04.017, 10.1016/j.jinf.2020.06.052]
[4]   Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease [J].
Goletti, Delia ;
Lee, Meng-Rui ;
Wang, Jann-Yuan ;
Walter, Nicholas ;
Ottenhoff, Tom H. M. .
RESPIROLOGY, 2018, 23 (05) :455-466
[5]   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J].
Huang, Chaolin ;
Wang, Yeming ;
Li, Xingwang ;
Ren, Lili ;
Zhao, Jianping ;
Hu, Yi ;
Zhang, Li ;
Fan, Guohui ;
Xu, Jiuyang ;
Gu, Xiaoying ;
Cheng, Zhenshun ;
Yu, Ting ;
Xia, Jiaan ;
Wei, Yuan ;
Wu, Wenjuan ;
Xie, Xuelei ;
Yin, Wen ;
Li, Hui ;
Liu, Min ;
Xiao, Yan ;
Gao, Hong ;
Guo, Li ;
Xie, Jungang ;
Wang, Guangfa ;
Jiang, Rongmeng ;
Gao, Zhancheng ;
Jin, Qi ;
Wang, Jianwei ;
Cao, Bin .
LANCET, 2020, 395 (10223) :497-506
[6]   Tocilizumab treatment in COVID-19: A single center experience [J].
Luo, Pan ;
Liu, Yi ;
Qiu, Lin ;
Liu, Xiulan ;
Liu, Dong ;
Li, Juan .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) :814-818
[7]   COVID-19: combining antiviral and anti-inflammatory treatments [J].
Stebbing, Justin ;
Phelan, Anne ;
Griffin, Ivan ;
Tucker, Catherine ;
Oechsle, Olly ;
Smith, Dan ;
Richardson, Peter .
LANCET INFECTIOUS DISEASES, 2020, 20 (04) :400-402
[8]   Cytokine storm intervention in the early stages of COVID-19 pneumonia [J].
Sun, Xinjuan ;
Wang, Tianyuan ;
Cai, Dayong ;
Hu, Zhiwei ;
Chen, Jin'an ;
Liao, Hui ;
Zhi, Liming ;
Wei, Hongxia ;
Zhang, Zhihong ;
Qiu, Yuying ;
Wang, Jing ;
Wang, Aiping .
CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 53 :38-42
[9]   Effective treatment of severe COVID-19 patients with tocilizumab [J].
Xu, Xiaoling ;
Han, Mingfeng ;
Li, Tiantian ;
Sun, Wei ;
Wang, Dongsheng ;
Fu, Binqing ;
Zhou, Yonggang ;
Zheng, Xiaohu ;
Yang, Yun ;
Li, Xiuyong ;
Zhang, Xiaohua ;
Pan, Aijun ;
Wei, Haiming .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (20) :10970-10975